Figure 1.

Longitudinal component patient profile. Longitudinal component patient profile showing screened patients, smear and rapid diagnostic test (RDT) results and the number that were followed up. At the beginning of the longitudinal component to evaluate persistent antigenicity of HRP2 RDTs, 259 children were enrolled on day-3. 224 remained in the study until an outcome was determined (at the end of the follow up when either the RDTs were negative or smear was positive due to recurrent parasitaemia).